Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world

Immunity

Volumn 8, Issue 6, 1998, Pages 657-665

  Srivastava, Pramod K ^a   Menoret, Antoine ^a   Basu, Sreyashi ^a   Binder, Robert J ^a   McQuade, Kristi L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN;

ADAPTATION; CANCER GENETICS; CELL FUNCTION; CELL PROTECTION; DROSOPHILA MELANOGASTER; GENE LOCATION; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0032101221     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80570-1     Document Type: Review

References (88)

1. Albert, M.L., Sauter, B., and Bhardwaj, N. (1998). Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86-89.
2. Arnold, D., Faath, S., Rammensee, H., and Schild, H. (1995). Crosspriming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182, 885-889.
3. Arnold, D., Wahl, C., Faath, S., Rammensee, H.G., and Schild, H. (1997). Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96. J. Exp. Med. 186, 461-466.
4. Barrios, C., Lussow, A.R., van Embden, J., Van der Zee, R., Rappuoli, R., Costantino, P., Louis, J.A., Lambert, P.M., and Del Giudice, G. (1992). Mycobacterial heat shock proteins as carrier molecules II: the use of the 70 kDa mycobacterial heat shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and BCG priming. Eur. J. Immunology 22, 1365.
5. Basombro, M.A. (1970). Search for common antigenicities among 25 sarcomas induced by methylcholanthrene. Cancer Res. 30, 2458.
6. Beck, G., and Habicht, G.S. (1996). Immunity and invertebrates. Sci. Am. 275, 60-63.
7. Bellone, M., Iezzi, G., Rovere, P., Galati, G., Ronchetti, A., Protti, M.P, Davoust, J., Rugarli, C., and Manfredi, A.A. (1997). Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159, 5391-5399.
8. Bevan, M. (1976). Minor H antigens introduced on H-2 different stimulating cells cross react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117, 2233-2238.
9. Blachere, N.E., Udono, H., Janetzki, S., Li, Z., Heike, M., and Srivastava, P.K. (1993). Heat shock protein vaccines against cancer. J. Immunother. 14, 352-356.
10. Blachere, N.E., Li, Z., Chandawarkar, R.Y., Suto, R., Jaikaria, N.S., Basu, S., Udono, H., and Srivastava, P.K. (1997). Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186, 1315-1322.
11. Boon, T., and van der Bruggen, P. (1996). Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725-729.
12. Burnet, F.M. (1957). A modification of Jernes theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20, 67-81.
13. Cahill, D.P., Lengauer, C., Yu, J., Riggins, G.J., Wilson, K.K.V., Markowitz, S.D., Kinzler, K.W., and Vogelstein, B. (1998). Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300-303.
14. Ciupitu, A.M.T., Petersson, M., O'Donnell, C.L., Williams, K., Jindal, S., Kiessling, R., and Welsh, R.M. (1998). Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J. Exp. Med. 187, 685-691.
15. Coggin, J.H., Jr., and Anderson, N.G. (1974). Cancer, differentiation and embryonic antigens: some central problems. Adv. Cancer. Res. 19, 105-165.
16. Coulie, P.G., Lehmann, F., Lethe, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. (1995). A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92, 7976-7980.
17. Donawho, C., and Kripke, M.L. (1990). Immunogenicity and cross-reactivity of syngeneic murine melanomas. Cancer Commun. 2, 101-107.
18. Flynn, G.C., Chappell, T.G., and Rothman, J.E. (1989) Peptide binding and release by proteins implicated as catalysts of protein assembly. Science 245, 385-390.
19. Frey, A.B., and Cestari, S. (1995). Expression of activated H-rasval12 in nontumorigenic and non-cross-reactive syngeneic cells induces tumor antigens cross-reactive with rat mammary adenocarcinoma 13762. J. Immunol. 155, 4783-4789.
20. Globerson, A., and Feldman, M. (1964). Antigenic specificity of benzo(a)pyrene induced sarcomas. J. Natl. Cancer, Inst. 32, 1229.
21. Gross, L. (1943). Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 3, 326-333.
22. Heikema, A., Agsteribbe, E., Wiscjut, J., and Huckriede, A. (1997). Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides. Immunol. Lett. 57, 69-74.
23. Hickey, R.J., and Malkas, L.H. (1997). Mammalian cell DNA replication. Crit. Rev. Eukaryot. Gene Expr. 7, 125-157.
24. Huang, A.Y., Gulden, P.M., Woods, A.S., Thomas, M.C., Tong, C.D., Wang, W., Engelhard, V.H., Pasternack, G., Cotter, R., Hunt, D., et al. (1996). The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl. Acad. Sci. USA 93, 9730-9735.
25. Hughes, E.A., and Cresswell, P. (1998). A thiol oxidoreductase (Erp57) is acomponent of the MHC class I peptide loading complex. Curr. Biol., in press.
26. Janetzki, S., Blachere, N.E., and Srivastava, P.K. (1998). Generation of tumor-specific cytotoxic T lymphocyted and memory T cells by immunization with tumor-derived heat shock protein gp96. J. Immunotherapy, in press.
27. Klein, G., Sjorgen, H.O., Klein, E., and Hellstrom, K.E. (1960). Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 20, 1561-1572.
28. Lammert, E., Arnold, D., Nijenhuis, M., Momburg, F., Hammerling, G.J., Brunner, J., Stevanovic, S., Rammensee, H.G., and Schild, H. (1997a). The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP. Eur. J. Immunol. 27, 923-927.
29. Lammert, E., Stevanovic, S., Brunner, J., Rammensee, H.G., and Schild, H. (1997b). Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum. Eur. J. Immunol. 27, 1685-1690.
30. Lederberg, J. (1959) Genes and antibodies. Science 129, 1669-1673.
31. Li, Z., and Srivastava, P.K. (1993). Tumor rejection antigen gp96/ grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J. 12, 3143-3151.
32. Lindquist, S., and Craig, E.A. (1988). The heat-shock proteins. Annu. Rev. Genet. 22, 631-677.
33. Lindquist, J.A., Jensen, O.N., Mann, M., and Hammerling, G.J. (1998). ER-60, achaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J. 77, 2186-2195.
34. Lussow, A.R., Barrios, C., van Embden, J., Van der Zee, R., Verdini, A.S., Pessi, A., Louis, J.A., Lambert, P.H., and Del Giudice, G. (1991). Mycobacterial heat shock proteins as carrier molecules. Eur. J. Immunology 22, 1365-1372.
35. Mandelboim, O., Vadai, E., Fridkin, M., Katz-Hillel, A., Feldman, M., Berke, G., and Eisenbach, L. (1995). Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nat. Med. 1, 1179-1183.
36. Marusina, K., Reid, G., Gabathuler, R., Jefferies, W., and Monaco, J.J. (1997). Novel peptide-binding proteins and peptide transport in normal and TAP-deficient microsomes. Biochemistry 36, 856-863.
37. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
38. Melcher, A., Todryk, A., Hardwick, N., Ford, M., Jacobson, M., and Vile, R.G. (1998). Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4, 581-587.
39. Menoret, A., Patry, Y., Burg, C., and Le Pendu, J. (1995). Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. J. Immunol. 155, 740-747.
40. Monach, P.A., Meredith, S.C., Siegel, C.T., and Schreiber, H. (1995). A unique tumor antigen produced by a single amino acid substitution. Immunity 2, 45-59.
41. Monaco, J.J. (1992). A molecular model of MHC class I-restricted antigen processing, Immunol. Today 13, 173-179.
42. Neisig, A., Wubbolts, R., Zang, X., Melief, C., and Neefjes, J. (1996). Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 756, 3196-3206.
43. Nieland, T.J., Tan, M.C., Monne-van Muijen, M., Koning, F., Kruisbeek, A.M., and vanBleek, G.M. (1996). Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl. Acad. Sci. USA 93, 6135-6139.
44. Nossner, E., and Parham, P. (1995). Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J. Exp. Med. 181, 327-337.
45. Nicchitta, C. (1998). Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/ gp96. Curr. Opin. Immunol. 10, 103-109.
46. Old, L.J. (1981). Cancer immunology: the search for specificity -G. H. A. Clowes memorial lecture. Cancer Res. 41, 361-375.
47. Old, L.J., Boyse, E.A., Clarke D.A., and Carswell, E.A. (1962). Antigenic properties of chemically induced tumors. Ann. N. Y. Acad. Sci. 101, 80.
48. Ortmann, B., Androlewicz, M.J., and Cresswell, P. (1994). MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368, 864-867.
49. Ortmann, B., Copeman, J., Lehner, P.J., Sadasivan, B., Herberg, J.A., Grandea, A.G., Riddell, S.R., Tampe, R., Spies, T., Trowsdale, J., and Cresswell, P. (1997), A critical role fortapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277, 1306-1309.
50. Ottaviani, E., and Franceschi, C. (1997). The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems, Immunol. Today 18, 169-174.
51. Palladino, M.A., Srivastava, P.K., Oettgen, H.F., and DeLeo, A.B. (1987). Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. I. Detection by a cloned cytotoxic T cell line. Cancer Res. 47, 5074-5079.
52. Peng, P., Menoret, A., and Srivastava, P.K. (1997). Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography. J. Immunol. Methods 204, 13-21.
53. Pratt, W.B., and Toft, D.O. (1997). Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306-360.
54. Prehn, R.T., and Main, J.M. (1957). Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18, 769.
55. Prodromou, C., Roe, S.M., Obrien, R., Ladbury, J.E., Piper, P.W., and Pearl, L.H. (1997a). Identification and structural characterization of the AYP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90, 65-75.
56. Prodromou, C., Roe, S.M., Piper, P.W., and Pearl, L.H. (1997b). A molecular clamp in the crystal structure of the N-terminal domain of the yeast hsp90-chaperone. Nat. Struct. Biol. 4, 477-482.
57. Ramarathinam, L., Castle, M., Wu, Y., and Liu, Y. (1994). T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med. 179, 1205-1214.
58. Ritossa, F. (1962). A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia 18, 571-573.
59. Robbins, P.F., El-Gamil, M., Li, Y.F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S.A. (1996). A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183, 1185-1192.
60. Rohrer, J.W., Rohrer, S.D., Barsoum, A., and Coggin, J.H., Jr. (1994). Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells. Immunology 152, 754-764.
61. Roman, E., and Moreno, C. (1996). Synthetic peptides non-covalently bound to bacterial hsp 70 elicit peptide-specific T-cell responses in vivo. Immunology 88, 487-492.
62. Roman, E. and Moreno, C. (1997) Delayed-type hypersensitivity elicited by synthetic peptides complexed with Mycobacterium tuberculosis hsp 70. Immunology 90, 52-56.
63. Sadasivan, B., Lehner, P.J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114.
64. Scheibel, T., Weikl, T., and Buchner, J. (1998). Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc. Natl. Acad. Sci. USA 95, 1495-1499.
65. Spee, P., and Neefjes, J. (1997). TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin. Eur. J. Immunol. 27, 2441-2449.
66. Srivastava, P.K. (1993). Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv. Cancer Res. 62, 153-177.
67. Srivastava, P.K. (1996). Do human cancers express shared protective antigens? Or the necessity of remembrance of things past. Semin, Immunol. 8, 295-302.
68. Srivastava, P.K., and Das, M.R. (1984). Serologically unique surface antigen of a rat hepatoma is also its tumor-associated transplantation antigen. Int. J. Cancer. 33, 417-422.
69. Srivastava, P.K., and Old, L.J. (1988). Individually distinct transplantation antigens of chemically induced mouse tumors, Immunol. Today 9, 78-83.
70. Srivastava, P.K., and Heike, M. (1991). Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin, Immunol. 3, 57-64.
71. Srivastava, P.K., and Maki, R.G. (1991). Stress-induced proteins in immune response to cancer. Curr. Top. Microbiol. Immunol. 167, 109-123.
72. Srivastava, P.K., DeLeo, A.B., and Old, L.J. (1986). Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA 83, 3407-3411.
73. Srivastava, P.K., Udono, H., Blachere, N.E., and Li, Z. (1994). Heat shock proteins transfer peptides during antigen p recessing and CTL priming, Immunogenetics 39, 93-98.
74. Stebbins, C.E., Russo, A.A., Rosen, N., Hartl, F.U., and Pavletich, N.P. (1997). Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an anti-tumor agent. Cell 89, 239-250.
75. Suto, R., and Srivastava, P.K. (1995). A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588.
76. Suzue, K., Zhou, X., Eisen, H.N., and Young, R.A. (1997). Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc. Natl. Acad. Sci. USA 94, 13146-13151.
77. Tamura, Y., Peng, P., Kang, L., Daou, M., and Srivastava, P.K. (1997). Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278, 117-120.
78. Tsubuki, S., Saito, Y., and Kawashima, S. (1994). Purification and characterization of an endogenous inhibitor specific to the Z-Leu-Leu-Leu-MCAdegrading activity inproteasome and its identification as heat-shock protein 90. FEBS Lett. 344, 229-233.
79. Udono, H., and Srivastava, P.K. (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178, 1391-1396.
80. Udono, H., and Srivastava, P.K. (1994). Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152, 5398-5403.
81. + T cells in vivo. Proc. Natl. Acad. Sci. USA 91, 3077-3081.
82. Ullrich, S.J., Robinson, E.A., Law, L.W., Willingham, M., and Appella, E. (1986). A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc. Natl. Acad. Sci. USA 83, 3121-3125.
83. Wearsch P.A., and Nicchitta, C.V. (1997). Interaction of endoplasmic reticulum chaperone GRP94 with peptide substrates is adenine nucleotide-independent. J. Biol. Chem. 272, 5152-5156.
84. Wearsch, P.A., Voglino, L., and Nicchitta, C.V. (1998). Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum hsp90 chaperone GRP94. Biochemistry 37, 5709-5719.
85. Wells, A.D., Rai, S.K., Salvato, M.S., Band, H., and Malkovsky, M. (1997). Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone. Scand. J. Immunol. 45, 605-612.
86. Williams, D.B., and Watts, T.H. (1995). Molecular chaperones in antigen presentation. Curr. Opin. Immunol. 7, 77-84.
87. Wolfel, T., Hauer, M., Schneider, J., Serrano, M., Wolfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Buschenfelde, K.H., and Beach, D. (1995). A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281-1284.
88. Zhu, X., Zhao, X., Burkholder, W.F., Gragerov, A., Ogata, C.M., Gottesman, M.E., and Hendrickson, W.A. (1996). Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272, 1606-1614.